Remix Therapeutics is a Biotech company based in Watertown, Massachusetts. It has raised $211M in total funding. Latest round: Growth.
Remix Therapeutics funding overview
Remix Therapeutics is a Biotech company based in Watertown, Massachusetts. Remix Therapeutics has raised $211M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in January 2024. The round record for Remix Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Atlas Venture, The Column Group, Foresite Capital, Surveyor Capital. 4 distinct backers are named across the disclosed rounds.
Remix Therapeutics at a glance
Total raised
$211M
Latest round
Growth
Latest round date
January 2024
Industry
Biotech
Headquarters
Watertown, Massachusetts
Notable investors
Atlas Venture, The Column Group, Foresite Capital, Surveyor Capital
Frequently asked about Remix Therapeutics funding
How much has Remix Therapeutics raised?
Remix Therapeutics has raised $211M in total disclosed funding across the rounds on record.
Who has invested in Remix Therapeutics?
Atlas Venture, The Column Group, Foresite Capital, Surveyor Capital are named among the investors backing Remix Therapeutics.
What was the latest Remix Therapeutics funding round?
The most recent disclosed round is a Growth, announced in January 2024.
Where is Remix Therapeutics based?
Remix Therapeutics is based in Watertown, Massachusetts.
What sector does Remix Therapeutics operate in?
Remix Therapeutics is tracked under Biotech from Watertown, Massachusetts, with $211M in disclosed funding.
When did Remix Therapeutics last raise?
The last disclosed Remix Therapeutics round closed in January 2024 at Growth.
Round data for Remix Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Watertown and backer lists below.
